Evidence map›Paper›PMID 42748171›Full record

ArticlePloS one2026

Developing an inclusive research (methods) strategy for the Manchester Biomedical Research Centre and Clinical Research Facility.

Anna Coleman, Sheela Medahunsi, Joanne Elliott, Jedidah Mould, Abin Thomas, Eliza Varga, Arpana Verma

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna ColemanInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-1866-7036
Sheela MedahunsiInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.
Joanne ElliottInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.
Jedidah MouldInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-6243-7975
Abin ThomasInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.
Eliza VargaInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.ORCID https://orcid.org/0009-0005-1333-0513
Arpana VermaInclusive Research Methods Team, NIHR Manchester Biomedical Research Centre and Clinical Research Facility, Division of Medical Education, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As funders of health and care research increasingly mandate inclusive research practices, the Manchester Biomedical Research Centre (BRC) and Clinical Research Facility (CRF) developed a comprehensive Inclusive Research (IR) Strategy to embed the principles of inclusivity across their experimental medicine research. This paper presents the co-production of the Strategy, shaped by collaboration between Inclusive Research Methods (IRM), Equality, Diversity and Inclusion (EDI), and Patient and Public Involvement and Engagement (PPIE) teams, alongside public contributors and wider stakeholders. The Strategy development was informed by iterative engagement, including workshops and one-to-one consultations, which revealed varying levels of understanding of IR and highlighted the need for accessible, evidence-informed approaches. It is structured around five strategic principles: mapping inequalities and protected characteristics; training and capacity building; working with communities and partners; establishing effective routes to delivery and using and creating Inclusive Research Methods. Key learning from the process includes the importance of aligning IR with existing organisational strategies, fostering inclusive governance through our Inclusive Research Oversight Board (IROB), and ensuring flexibility to adapt to emerging national guidance-such as National Institute for Health and Care Research's (NIHR) 10-step framework for inclusive research design or Core20PLUS5 - and the ongoing cycles of evaluation across the BRC/CRF programmes. Stakeholder feedback also underscored the value of co-production, the need to dismantle power dynamics, and the importance of clarity, accountability, and responsiveness in strategic implementation. The IR Strategy demonstrates how inclusive research can be operationalised within a complex translational research infrastructure. It offers a replicable model for embedding inclusive practices across the research lifecycle, leading to more equitable participant recruitment, enhanced research relevance, and health research with greater impact for all, including under-served populations. By fostering team research and an inclusive culture where inclusivity is business as usual, the IR Strategy seeks to drive meaningful change in health and care research, ensuring it is representative, accessible, and beneficial to all over the longer term.

Indexed as

Biomedical ResearchResearch DesignDiversity, Equity, InclusionHumans

Identifiers

PMID42748171
PMCPMC13581002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.